Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jul 2021 - Jun 2022
Lobbyists (Full time equivalent)
0.75 Fte (2)
Lobbyists with EP accreditation
1
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
All.Can International
EU Transparency Register
025568638034-92 First registered on 05 May 2020
Goals / Remit
All.Can International is a global, multi-stakeholder initiative to inform and generate political and public engagement on the need to improve the efficiency of cancer care, by focusing on what really matters to patients and the society. All.Can seeks to make sure resources are directed towards achieving better health outcomes while contributing to health systems’ overall sustainability.
All.Can's objectives are:
1. Advancing thought leadership in cancer care efficiency
2. Driving cancer care policy & multi-stakeholder dialogue
3. Improving cancer care control, systems & pathways globally & locallyMain EU files targeted
• Europe’s Beating Cancer Plan
• Horizon Europe Cancer Mission
• European Health Data Space
• EU4Health
• SmartCardAddress
Head Office
Rue du Luxembourg 22-24
Brussels 1000
BELGIUMEU Office
Rue du Luxembourg 22-24
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 50% 1 25% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 05 Sep 2022
Name Start date End Date Mr Eduardo PISANI 06 Dec 2022 06 Dec 2023 Mr Eduardo PISANI 24 Nov 2021 24 Nov 2022 Complementary Information
All.Can does not have any direct employees. The information above relates to freelance and consultant staff.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
Union for International Cancer Control (UICC);
European Alliance for Value in Health (EAVH)Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jul 2021 - Jun 2022
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
460,000€
Major funding types in closed year
Member's contribution
Major contributions in closed year
Type Name Amount Contribution Bristol Myers Squibb (BMS) 250,000€ Contribution Roche 75,000€ Contribution MSD 60,000€ Contribution Janssen 40,000€ Contribution Baxter 15,000€ Contribution Illumina 20,000€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Cancer
Communication activities
In 2019, All.Can published the findings of a patient survey conducted in over 10 countries with almost 4,000 cancer patients and carers, revealing where they identified inefficiencies in their care.
In 2021, All.Can published a policy report entitled ‘Harnessing data for better cancer care', assessing the essential role of data in cancer care to improve outcomes for all people with cancer, and offering policymakers, care providers, patients and decision-makers a forward-looking recommendations on how to ensure high-quality health data are systematically collected and used to improve outcomes for patients across the entire cancer care pathway.
In 2022, All.Can published its ‘Building efficiency in cancer care’ policy blueprint, offering a common, broadly applicable framework to support collaborative policy action to improve efficiency in cancer care, for better patient outcomes and more sustainable healthcare systems.
On 17 June 2022, All.Can published its Efficiency Metrics study, a policy research which proposes a set of internationally applicable and real-world measures generated and collected from daily clinical practice. The report can be used by relevant stakeholders to assess efficiency in cancer care and aims to harmonise and set standards in cancer care efficiency globally. https://www.all-can.org/what-we-do/policy-research/all-can-efficiency-metrics-study/Other activities
n/a
- Meetings
Meetings
None declared
- Meetings